Apellis Pharmaceuticals, Inc. financial data

Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Fifth Avenue, Waltham, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 396 % -30.6%
Quick Ratio 68.4 % +22%
Debt-to-equity 249 % +34.1%
Return On Equity -139 % +34.7%
Return On Assets -39.8 % +46.5%
Operating Margin -49.8 % +85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122M shares +3.42%
Common Stock, Shares, Outstanding 122M shares +3.49%
Entity Public Float 10.7B USD +123%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 124K shares +3.85%
Weighted Average Number of Shares Outstanding, Diluted 124K shares +3.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 629M USD +241%
Research and Development Expense 311M USD -22.2%
General and Administrative Expense 501M USD +80.7%
Operating Income (Loss) -313M USD +48.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -331M USD +49.7%
Income Tax Expense (Benefit) 1.94M USD -41.2%
Net Income (Loss) Attributable to Parent -333M USD +49.3%
Earnings Per Share, Basic -2.71 USD/shares +53.7%
Earnings Per Share, Diluted -2.71 USD/shares +53.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 360M USD -41.6%
Marketable Securities, Current 124M USD -15.1%
Accounts Receivable, after Allowance for Credit Loss, Current 304M USD +174%
Inventory, Net 153M USD +48%
Other Assets, Current 12.4M USD -53.9%
Assets, Current 860M USD -3.66%
Property, Plant and Equipment, Net 3.84M USD -28.2%
Operating Lease, Right-of-Use Asset 16.3M USD -2.42%
Other Assets, Noncurrent 1.33M USD +60.8%
Assets 904M USD -1.21%
Accounts Payable, Current 38.3M USD +39.2%
Accrued Liabilities, Current 123M USD +25.7%
Liabilities, Current 169M USD -3.24%
Operating Lease, Liability, Noncurrent 11.1M USD -8.13%
Other Liabilities, Noncurrent 2.69M USD +527%
Liabilities 640M USD +12.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.36M USD -322%
Retained Earnings (Accumulated Deficit) -2.94B USD -12.8%
Stockholders' Equity Attributable to Parent 264M USD -23.5%
Liabilities and Equity 904M USD -1.21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -133M USD +25.1%
Net Cash Provided by (Used in) Financing Activities 108M USD -72.3%
Net Cash Provided by (Used in) Investing Activities -293K USD -13.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 122M shares +3.49%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.3M USD -112%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 361M USD -41.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.64M USD 0%
Deferred Tax Assets, Valuation Allowance 753M USD +18.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 756M USD +18%
Operating Lease, Liability 17.3M USD -3.46%
Depreciation 444K USD +5.46%
Payments to Acquire Property, Plant, and Equipment 293K USD +13.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -335M USD +48.8%
Lessee, Operating Lease, Liability, to be Paid 19M USD -5.57%
Operating Lease, Liability, Current 6.21M USD +6.19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.89M USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.65M USD +3.66%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -13.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.67M USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD -67.5%
Deferred Tax Assets, Operating Loss Carryforwards 329M USD +43.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 859K USD -79.9%
Operating Lease, Payments 2.31M USD +14.3%
Additional Paid in Capital 3.21B USD +8.61%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%